NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development Industry News January 10, 2023 …
How Organ-on-a-chip Models Could Grease the Drug Development Pipeline Medical Countermeasures January 10, 2023 …
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs Industry News June 20, 2022 …
ATCC Announces Awards from DTRA Supporting Global Health and Biodefense Industry News February 15, 2022 …
Zika Virus Vaccine Shows Promising Results in Preclinical Studies Medical Countermeasures February 6, 2022 …
Preclinical Studies Support Army’s Pan-Coronavirus Vaccine Development Strategy Medical Countermeasures December 16, 2021 …
Stopping Lethal Anthrax Using an Enzyme to Disrupt the Bacterial Capsule Defense + Military December 8, 2021 …
Erica Ollmann Saphire Receives $2.6M Grant to Collaborate on Pan-Coronavirus Vaccine Contracts + Grants October 23, 2021 …
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines Contracts + Grants October 21, 2021 …
Tonix Pharmaceuticals Opens Infectious Disease R&D Center in Maryland Industry News October 18, 2021 …
New Antiviral Compound Blocks SARS-CoV-2 From Entering Cells Medical Countermeasures October 13, 2021 …
Understanding How the Microbiome Affects Radiation Injury for Countermeasure Development CBRNE October 11, 2021 …
Breakthrough Results for Dengue Antiviral: Janssen Compound Shows Promise Against All Serotypes Industry News October 6, 2021 …
Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine Medical Countermeasures October 4, 2021 …
Made-in-Melbourne mAbs Could Bolster Australia’s COVID Response Medical Countermeasures September 29, 2021 …
